COMMUNIQUÉS West-GlobeNewswire

Opportunity to Invest: CORAnet® Solutions — Leading the Future of Interoperable Mobile Health Records
01/05/2025
WASHINGTON, D.C., May 01, 2025 (GLOBE NEWSWIRE) -- CORAnet® Solutions, Inc. is excited to announce a unique investment opportunity as we continue to revolutionize healthcare data access through cutting-edge technologies [...]
Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback
01/05/2025
Company initiates formal regulatory engagement on trial design for Alzheimer’s, dementia, and MCI indications HOUSTON, TX, May 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or [...]
NewGenIVF Announces Reverse Stock Split
01/05/2025
BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to [...]
D'un océan à l'autre pour la guérison en appui à Percée DT1(MC) Canada
01/05/2025
Matt Varey, un membre du conseil d’administration de Percée DT1, traverse le Canada à vélo pour appuyer la recherche sur le diabète de type 1 TORONTO, 01 mai 2025 (GLOBE NEWSWIRE) -- À compter du 3 mai, Matt Varey, vice [...]
Coast-to-Coast for Cures in support of Breakthrough T1D™ Canada
01/05/2025
Breakthrough T1D Board Member Matt Varey is cycling across Canada in support of type 1 diabetes research TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Beginning May 3, 2025, Matt Varey, retired banking executive, Vice Chair [...]
NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time
01/05/2025
EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination
01/05/2025
18 presentations across five cancer types include new insights on the potential of checkpoint inhibitors and bispecific antibodies TARRYTOWN, N.Y., May 01, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. ( [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain
01/05/2025
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses key learnings from initial trial phase (“POC 1”) where clinically meaningful pain reduction was demonstrated Outlines Company’s plans to initiate market [...]
Celebrity Trainer Pieter Vodden Partners with Campio to Promote Daily Joint Support for Active Lifestyles
01/05/2025
Campio has teamed up with fitness expert Pieter Vodden — trainer to Hollywood stars — to help consumers stay active and pain-free through smarter joint support. PALOS VERDES ESTATES, Calif., May 01, 2025 (GLOBE NEWSWIRE [...]
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
01/05/2025
Research highlights AAV manufacturing optimization via Lexeo’s Sf9-baculovirus process NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company [...]
SRx Health Solutions to Consider Allocating Up to 10% of Future Cash Flows and Cash Reserves to Bitcoin, Solana and Gold
01/05/2025
TAMPA, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that it will explore an initiative to [...]
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
01/05/2025
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and [...]
Senti Bio Releases Virtual Investor “What This Means” Segment
01/05/2025
Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio discusses the positive data from lead program, SENTI-202, recently presented at the American Association for Cancer Research ( [...]
Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025
01/05/2025
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
01/05/2025
Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company "), an artificial intelligence ("AI")-powered medical technology company focused on transforming [...]
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
01/05/2025
John Woock joins as Chief Business Officer; Konstantinos Alataris, PhD, appointed to Board of Directors NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a pioneering brain– [...]
Eleos Advances Comprehensive Behavioral Health Product Capabilities
01/05/2025
The new Eleos Documentation experience brings industry-leading augmented intelligence tools to more behavioral health use cases, 150+ languages, and rural or offline care settings Eleos dives deeper into Spring product [...]
Resmed Acquires VirtuOx
01/05/2025
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD [...]
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
01/05/2025
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD data from the [...]

Pages